ResMed is betting big on artificial intelligence (AI) to boost CPAP adherence. At the recent J.P. Morgan Healthcare Conference, CEO Mick Farrell said the company’s first AI-enabled medical device, Sma ...
As Philips’ recall of many of its CPAP and BiPAP machines and other respiratory devices grew to include more machines and sparked tens of thousands of patient complaints, ResMed stepped up to fill ...
StockStory.org on MSN
Reflecting on patient monitoring stocks’ Q3 earnings: ResMed (NYSE:RMD)
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...
ResMed (NYSE:RMD) intends to keep its CPAP masks that utilize magnets on the market despite a recall because it regards the action as a labeling correction rather than a product removal. According to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback